Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 63 of 195
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

BSF Enterprise to acquire 3D Bio-Tissues

The acquisition of 3DBT for the consideration amount is to be satisfied by the issuance to the sellers of a total of 33,900,003 consideration shares at 7.37 pence